key: cord-0710441-y448xjf3
authors: Caliskan, Ufuk Koca; Karakus, Methiye Mancak
title: Evaluation of botanicals as potential COVID-19 symptoms terminator
date: 2021-10-21
journal: World J Gastroenterol
DOI: 10.3748/wjg.v27.i39.6551
sha: 0adb16405c7b94b4e7b292adab994fde1ea0ce35
doc_id: 710441
cord_uid: y448xjf3

Information about the coronavirus disease 2019 (COVID-19) pandemic is still evolving since its appearance in December 2019 and has affected the whole world. Particularly, a search for an effective and safe treatment for COVID-19 continues. Botanical mixtures contain secondary metabolites (such as flavonoids, phenolics, alkaloids, essential oils etc.) with many therapeutic effects. In this study, the use of herbal treatments against COVID-19 was evaluated. Medical synthetic drugs focus mainly on respiratory symptoms, however herbal therapy with plant extracts may be useful to relieve overall symptoms of COVID-19 due to the variety of bioactive ingredients. Since COVID-19 is a virus that affects the respiratory tract, the antiviral effects of botanicals/plants against respiratory viruses have been examined through clinical studies. Data about COVID-19 patients revealed that the virus not only affects the respiratory system but different organs including the gastrointestinal (GI) system. As GI symptoms seriously affect quality of life, herbal options that might eliminate these problems were also evaluated. Finally, computer modeling studies of plants and their active compounds on COVID-19 were included. In summary, herbal therapies were identified as potential options for both antiviral effects and control of COVID-19 symptoms. Further data will be needed to enlighten all aspects of COVID-19 pathogenesis, before determining the effects of plants on severe acute respiratory syndrome coronavirus 2.

New coronavirus disease 2019 (COVID-19), which emerged in Wuhan in December 2019, spread rapidly and affected the whole world. The emergence, epidemiology, origin and evolution of COVID-19 has been extensively studied by Sun et al [1] .

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown to carry out viral replication in the human host mainly through three main proteins and enzymes: 3-chymotrypsin-like protease (3CLpro), angiotensin-converting enzyme-2 (ACE2) and spike protein (TMPRSS2) [2, 3] . ACE2 receptors are found in the body not only in the lungs but also in tissues such as the endothelium, heart, kidney and intestine [2] . This distribution makes many organs a target of COVID-19. The significance of ACE2, which is found in intestinal tissues, especially for amino acid uptake from foods, has been emphasized and it has been suggested that the intestine may be an important entry site for SARS-CoV-2[2-4] Azithromycin, chloroquine, lopinavir, remdesivir, ritonavir are options used in treatment and whose effects are evaluated [5] . Effective and safe drugs and vaccines are sought all over the world to prevent novel coronavirus. Minerals, herbs, herbal products, probiotics and vitamins are the main natural resources, whose effectiveness and also the usability of herbal medicines in COVID-19 were investigated and benefit, risk assessments were evaluated [6] [7] [8] . Truly, since the beginning of the COVID-19, herbal medicines have been used in China. A study has shown that 90% of the 214 patients were treated with the traditional herbal medicine, moreover, it is reported that some of them prevented COVID-19 infection in healthy individuals and enhanced the health state of patients with mild or severe symptoms[9,10]. Health scientists from the Zhongnan Hospital of Wuhan University included the use of traditional medicines in the guidelines for the treatment and prevention of COVID-19. The experts recommended using medicinal plants for the prevention of COVID-19, additionally, the use of different herbal mixtures were recommended according to the disease-stage [11] .

Herbs and herbal products provide generous sources of primary and mostly secondary metabolites, which are valuable compounds (phenolics, flavonoids, tannins, alkaloids, essential oils, etc.) for prophylactic and chronical therapeutic purposes. Some of these metabolites in herbs and herbal mixtures have high chemical variety than the synthetics in stopping viral proliferations, and having antiviral activities [12] . Thus, botanicals can both show antiviral effects and relieve the symptoms of COVID-19 thanks to the different substance groups, which demonstrate different biological effects that will not be possible to achieve with a single synthetic drug. Based on this understanding, in this review, we offer all the potential interventions for COVID-19 infection according to previous and recently found antiviral effects of herbals. Considering the major transmission routes of COVID-19, where mostly ACE2 receptors found and the symptoms, the plants have been handled especially with their effects on the mostly respiratory and also gastrointestinal (GI) systems. Although ACE2, is typically expressed in epithelial cells of the airways, various GI symptoms in COVID-19 might be explained by the high expression of ACE2 in the digestive tract. Additionally, liver tests abnormalities, active viral replication in GI tract and patients' manifestations with GI symptoms (abdominal pain, diarrhea, nausea, vomiting) and possible fecal-oral transmission reveal the GI involvement in COVID-19 [13] .

Recent findings demonstrated that early blocking of COVID-19 with ACE2 inhibitors was one of the mechanisms used by novel drugs [14] , on the other hand diabetes mellitus and hypertension enhanced the risk of COVID-19 infection, in spite of using ACE2 inhibitors[15-17]. Furthermore, unpredicted ACE2 upregulation by ACE2 inhibitors, ibuprofen and angiotensin II type-I receptor blockers lead to need of identifying/using alternative ACE2 blockers [18] . Consequently, botanicals or natural products might be alternatively and selectively might block the ACE2 receptors without inhibiting the enzyme activity in order to treat and/or prevent COVID-19 spread in humans without increasing ACE2 expression in patients and therefore increased risk for COVID-19 [19] .

Clinical human studies showing the effect of plants on respiratory infections are presented as a table. Based on the pharmacological properties of plants, their practicality on COVID-19 symptoms have been evaluated. In the last part of the article, plants that inhibit ACE receptors, the research studies and their active compounds on COVID-19 also included and it is aimed to examine the plants from a broad perspective. 

Cough and fever are common symptoms in patients with COVID-19, including fatigue, shortness of breath, headache, muscle pain, sore throat, sputum, hemoptysis, diarrhea, dyspnea, rhinorrhea, chest pain, nausea, and vomiting [23] . COVID-19 symptoms in children are similar to those in adults and are relatively mild [24] .

Although, the current synthetic drugs focus on mainly respiratory symptoms, herbal therapy can be used to relieve overall symptoms of COVID-19 with their bioactive ingredients [25] . The meta-analysis study, which included randomized controlled trial studies, found significant effects of the combination of western medicine and herbal therapies. Combined treatment has been effective in cough, fever, dry and sore throat, fatigue and overall GI symptoms. The combined therapy significantly improved the disappearance rate of cough and sputum production [26] . In another meta-analysis, it was found that the addition of Chinese herbal medicine for standard care improved the symptoms and signs of COVID-19 as well as decreased levels of C-reactive protein [27] . The effects of plants that can alleviate the symptoms of COVID-19 are summarized in Table 3 . In addition, plants regarded as ACE inhibitors are shown in Table 4 .

In recent years, artificial intelligence has often been used to discover natural products as medicine [28, 29] . After the outbreak of COVID-19, computer models were used to investigate the effect of many plants and their components on SARS-CoV-2. Khaerunnisa et al [30] , determined the COVID-19 Main Protease (Mpro) inhibitor effects of medicinal plant components in a molecular docking study. They suggested apigenin-7-glucoside, curcumin, catechin, demethoxycurcumin, epicatechin-gallate, luteolin-7-glucoside, and oleuropein, as potential inhibitors of COVID-19 Mpro. In a similar molecular docking study using sixty-seven molecules of natural origin, crocin, digitoxigenin and b-eudesmol were proposed as inhibitors against coronavirus [31] . Another study was carried out using one hundred seventy-one essential oil components. The study determined the best docking ligands for the SARS-CoV target proteins were (E)--farnesene, (E,E)--farnesene and (E,E)-farnesol, thereby suggesting essential oil components may act synergistically with other antiviral agents, or they may provide some relief of COVID-19 symptoms [32] . Computer modeling studies and clinical studies against SARS-CoV-2 in some prominent plants/products and their metabolites are given below.

Utomo and Meiyanto[33] revealed the potential of several compounds of Curcuma longa against SARS-CoV-2 by binding to three protein receptors (RBD-S, PD-ACE2, SARS-CoV-2 protease). They showed that Curcuma sp. compounds can bind to target receptors, thus, have potential inhibitory effects on SARS-CoV-2 infectivity. Rajagopal et al [34] showed in their in silico docking study that Curcuma longa components could be effective against COVID-19 by inhibiting the SARS-CoV-2 Mpro enzyme. Morever, cyclocurcumin and curcumin possess significant binding at the active site of SARS-CoV-2 Mpro when compared to hydroxychloroquine and nelfinavir. When compared to remdesivir, cyclocurcumin is significantly more active [Glide score: Cyclocurcumin (−6.77); remdesivir (−6.38); curcumin (−6.13); nelfinavir (−5.93); hydroxychloroquine (− 5.47)]. In a similar study, diacetylcurcuminin was more effective on COVID-19 (Mpro) than nelfinavir [35] . Another study suggested the use of curcumin with hydroxychloroquine to destabilize the SARS-CoV2 receptor proteins [36] . Gonzalez-Paz et al [37] showed that curcumin strongly binds to 3CL-protease of COVID-19 Curcumin caused enzyme folding and structural changes in viral protease. Moreover, curcumin bound more strongly to the enzyme than chloroquine. Sharma[38] suggested that eucalyptus essential oil active compounds are potential inhibitors of COVID-19 Mpro. They conducted a molecular docking study to evaluate Tóth et al [176] , 2018

Anti-inflammatory Khan et al [177] , 2015

Antiplatelet, antithrombotic Lee et al [178] , 2017

Antitussives Bera et al [179] , 2016 GI protection Nanjundaiah et al [180] , 2011

Hepatic protection Ajith et al [181] , 2007

Zingiber officinale (Ginger)

Ajith et al [182] , 2007 insertion of eucalyptus active ingredients into Mpro, showed that the α-gurjune of eucalyptus, aromadene and allo-aromadene components have strong binding energy.

Sinha et al [43] conducted molecular docking simulation studies of two antiviral drugs (lopinavir and ribavirin) and 20 compounds of Glycyrrhiza glabra. Two protein targets from COVID-19 have been identified: Non-structural protein-15 endoribonuclease and spike glycoprotein. Glycyrrhizic acid prevented the virus from entering the host cell, due to its bulky structure. Gliasperin A showed high affinity to Nsp15 endoribonuclease and inhibited its activity. The authors suggested that glycyrrhizic acid disrupts the connection of the virus with the ACE2 receptor at the input level, and Gliasperin A inhibits the replication process of the virus after it enters the host cell.

Another study showed that glycyrrhizin can be highly bound to Mpro[44]. Liu et al[45] investigated the in vitro effect of Scutellaria baicalensis and its components on COVID-19. Baicalein (its main ingredient) and the ethanol extract of the plant inhibited the 3CLpro activity and replication of COVID-19. The ethanol extract also inhibited viral entry. Udrea et al [46] suggested the benefit Scutellaria baicalensis flavones (especially baicalein) against respiratory damage caused by COVID-19. Flavones bound to 3CLpro. strongly bound to wogonin flavone, nitric oxide synthase and cyclooxygenase 2. In addition, norwogonin and baicalein arachidonate modulated 15-lipoxygenase and lysine-specific demethylase 4D analogue.

In a randomized clinical study conducted on patients suffering from COVID-19, it was found that Thymus vulgaris strengthens the immune system and can be used to reduce COVID-19 symptoms. In the study, 83 COVID-19 patients were randomly divided into the control group and the group receiving thyme (TRG). TRG was given as thyme essential oil three times a day for seven days. A questionnaire asking about symptoms such as fever, cough, fatigue, and loss of appetite was completed before and at the end of treatment to determine the effect of thyme on symptoms. Thyme essential oil significantly reduced the severity of symptoms such as fever, cough, shortness of breath, dizziness, muscle pain, anorexia, weakness and lethargy and fatigue. [190] , 2015

Glycyrrhiza glabra Glycyrrhizic acid SARS-CoV-2/Glycyrrhizic acid disrupts the connection of the virus with the ACE2 receptor at the entry level

Hibiscus sabdariffa anthocyanins

Ojeda et al [191] , 2010

Linum usitatissimum (Flaxseed)

Secoisolariciresinol diglucoside ACE inhibition Prasad et al [192] , 2013 

In this study, the concept of "being effective against COVID-19" for herbal treatments was discussed from the angles of antiviral effect and control of symptoms, specifically related to GI system. October 21, 2021 Volume 27 Issue 39

Since COVID-19 is a virus that mainly affects the respiratory tract, the antiviral effects of medicinal plants against respiratory viruses have been examined firstly. The structure similarities of SARS-CoV-2 have been found with SARS-CoV and Middle East respiratory syndrome coronavirus. Therefore, it can be suggested that plants and their compounds affecting these viruses may also be potential treatment options for COVID-19. Here firstly, clinical studies supporting antiviral effects of 22 plant on respiratory viruses has been reviewed which determined that glycyrrhizic acid derivatives obtained from Glycyrrhiza sp, Nigella sativa, Scutellaria baicalensis and Torreya nucifera have anti-COVID-19 effects. Plants such as Allium sativum, Glycyrrhiza glabra, Melaleuca sp, Withania somnifera have been shown to bind to ACE2 receptors that are imperative for COVID-19 replication. Focusing on these plants might be a logical way to go for herbal treatment against COVID-19. This review also showed the antiviral effects of essential oils obtained from plants have the potential to affect COVID-19. The treatment involves using inhaled steam supplemented by essential oils possessing natural antimicrobial properties, oropharyngeal sanitization, as well as they are remedies for symptomatic relief. Inhalation of antimicrobial essential oils may help attenuate the virus in the nasal cavity, nasopharynx, oropharynx, and laryngopharynx. Antiseptic mouthwashes and gargles can also help to sanitize the oral cavity and oropharynx, whereas antiseptic lozenges can help to sanitize the oro-and laryngopharynx as well. The steam will carry the tiny particles of the antimicrobial constituents from these essential oils into the respiratory tract and is likely to improve the efficacy of the steam treatment. The steam supplemented by antimicrobial volatile oils may help to provide a local antimicrobial effect within the airways.

There are computer model studies showing that some botanicals and active ingredients are effective in COVID-19. Allium sativum, Curcuma longa, Eucalyptus globulus, Glycyrrhiza glabra, Melaleuca sp, Thymus vulgaris, Withania somnifera is among these plants. These studies with commonly found plants will guide future studies to develop effective supplements or drugs for COVID-19.

Since the symptoms of COVID-19 seriously affect the quality of life, herbal options to eliminate them were also evaluated in this review. Previously, herbs such as garlic, echinacea and ginseng were found to reduce the symptoms of cold in healthy individuals. Plants with their pharmacological effects are natural options for eliminating the symptoms of COVID-19. Based on the effects described in Table 3 , Allium sativum, Curcuma longa, Scutellaria baicalensis and Zingiber officinale are easily found as prominent plants to eliminate the GI symptoms of COVID-19. For example, ginger can eliminate the negative effects of COVID-19 on the GI system with its antiemetic and hepatic protective properties. A clinical study was conducted with thyme essential oil on COVID-19. Thyme essential oil was found to significantly reduce COVID-19 symptoms. This revealed an option that thyme and essential oil have potential effects for consideration in treatment of COVID-19. Studies on more essential oils of eucalyptus reveal more effects of eucalyptus on respiratory system symptoms. Eucalyptus globulus, Hedera helix, Pelargonium sidoides, Sambucus nigra, Thymus vulgaris can be recommended for relief of respiratory symptoms. ACE2 receptors are found in tissues other than the lung, such as the intestine. Based on this fact, we concluded that the use of herbs binding to ACE2 receptors can eliminate the side effects that may occur in variety of organs including GI tract. As shown in Table 4 Based on these studies, herbal treatments offer several potential treatments of COVID-19. Plants may be an option for the treatment of COVID-19 and its symptoms, as well as protection from COVID-19. Even though these data point to good outcomes there is always the possibility of interaction between drugs used and these herbs. For instance, herbs such as ginger with antithrombotic effects can be beneficial on COVID-19 symptoms, but one might be cautious about escalated risk of bleeding when it is used together with antithrombotic or anticoagulant drugs. Therefore, it is extremely important to avoid the indiscriminate use of plants.

For a plant to be used as a medicine, its effect must be supported by clinical studies. COVID-19 is just emerging, and more research are needed for its treatment. Yet, herbal therapies are potential options for both antiviral effects and the control of COVID-19 symptoms. Since plants with multiple pharmacological effects can affect many systems October 21, 2021

Volume 27 Issue 39 (respiratory, GI, and nervous), herbs might be more effective against COVID-19 than synthetic drugs. But first, all aspects of SARS-CoV-2 need to be examined. Then, the effects of plants on this virus should be determined by further studies.

Unlike other studies, in this report, the effect of plants on COVID-19 was evaluated in several ways. Preclinical studies, clinical studies and silico studies are included in this review. Moreover, the efficacy on COVID-19 symptoms has been addressed by including different systems. On the other hand, the focus is on the respiratory and GI systems. The effects, not only of botanicals but also active metabolites of have been studied.

The biggest limitation of this study is the lack of sufficient studies on the efficacy of botanicals. Since botanical studies are generally preclinical studies, results may vary due to conducting and including clinical studies. In clinical studies showing the effects of the plants in Table 2 on respiratory tract infections, the results were generally obtained with questionnaire studies. Placebo effects and breadth of study may be effective in positive results. 

Treatment of acute bronchitis with EPs 7630: Randomized, controlled trial in children and adolescents

Extracts of black garlic exhibits gastrointestinal motility effect

Garlic supplemented diet attenuates gentamicin nephrotoxicity ın rats

Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: A double-blind multicenter randomized placebo controlled three-arm study": authors' reply

Curcumin in turmeric: Basic and clinical evidence for a potential role in analgesia

Effect of curcumin supplementation on physiological fatigue and physical performance in mice

Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestylerelated Diseases

Acute Lung Injury: IL-17A-Mediated Inflammatory Pathway and Its Regulation by Curcumin

Preventive effects of curcumin against drug-and starvation-induced gastric erosions in rats

Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs

Therapeutic potential of curcumin in digestive diseases

Herbal polysaccharides and cough reflex

Antitussive and expectorant activities of licorice and its major compounds

Glycyrrhizic acid and 18beta-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3beta signaling and glucocorticoid receptor activation

Protective effects of glycyrrhizin against β₂-adrenergic receptor agonist-induced receptor internalization and cell apoptosis

The impact of formulation attributes and process parameters on black seed oil loaded liposomes and their performance in animal models of analgesia

Thymoquinone Modulates Blood Coagulation in Vitro via Its Effects on Inflammatory and Coagulation Pathways

Montelukast vs Nigella sativa for management of seasonal allergic rhinitis: A single blind comparative clinical trial

Evaluation of topical black seed oil in the treatment of allergic rhinitis

Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review

Nigella sativa oil with a calorie-restricted diet can improve biomarkers of systemic inflammation in obese women: A randomized double-blind, placebo-controlled clinical trial

Antiasthmatic effect of Nigella sativa in airways of asthmatic patients

Effect of Nigella sativa supplementation on lung function and inflammatory mediatorsin partly controlled asthma: a randomized controlled trial

Adaptogenic effects of Panax ginseng on modulation of immune functions

Evaluation of pharmacodynamic activities of EPs ® 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis

Scutellaria baicalensis decreases ritonavir-induced nausea

Flavonoids Identified from Korean Scutellaria baicalensis Georgi Inhibit Inflammatory Signaling by Suppressing Activation of NF-κ B and MAPK in RAW 264.7 Cells

Scutellaria baicalensis and a constituent flavonoid, baicalein, attenuate ritonavir-induced gastrointestinal side-effects

Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota

Ethanol extracts of Scutellaria baicalensis protect against lipopolysaccharide-induced acute liver injury in mice

Activations of GABAergic signaling, HSP70 and MAPK cascades are involved in baicalin's neuroprotection against gerbil global ischemia/reperfusion injury

Baicalein, wogonin, and Scutellaria baicalensis ethanol extract alleviate ovalbumin-induced allergic airway inflammation and mast cellmediated anaphylactic shock by regulation of Th1/Th2 imbalance and histamine release

Using species of the Lamiaceae family for musculoskeletal pain

Comparative effect of Thymus vulgaris and ibuprofen on primary dysmenorrhea: A triple-blind clinical study

Human platelet aggregation inhibitors from thyme (Thymus vulgaris L.)

Chemical characterization, antioxidant and anti-inflammatory properties of Greek Thymus vulgaris extracts and their possible synergism with Egyptian Chlorella vulgaris

Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study

Evaluation of analgesic activity of standardised aqueous extract of Withania somnifera in healthy human volunteers using mechanical pain model

Antiplatelet, anticoagulant, and profibrinolytic activities of withaferin A

Evaluation of anti-inflammatory effect of Withania somnifera root on collageninduced arthritis in rats

An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, doubleblind, placebo-controlled study

Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine

Efficacy and safety of ginger in osteoarthritis patients: A meta-analysis of randomized placebo-controlled trials

Zingiber officinale): An alternative for the prevention of postoperative nausea and vomiting. A meta-analysis

Zingiber officinale ameliorates allergic asthma via suppression of Th2-mediated immune response

Anti-factor Xa activities of zingerone with anti-platelet aggregation activity

Structural Elements and Cough Suppressing Activity of Polysaccharides from Zingiber officinale Rhizome

Gastroprotective Effect of Ginger Rhizome ( Zingiber officinale) Extract: Role of Gallic Acid and Cinnamic Acid in H(+), K(+)-ATPase/H. pylori Inhibition and Anti-Oxidative Mechanism

Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status

Zingiber officinale Roscoe alone and in combination with alphatocopherol protect the kidney against cisplatin-induced acute renal failure

In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria

Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil

Camellia sinensis) and links to processing method

Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection

Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain

Discovery of a potent angiotensin converting enzyme 2 inhibitor from Chinese medicinal and edible plant via docking-based virtual screening

Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean

Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin-and cyanidin-3-Osambubiosides from Hibiscus sabdariffa

SDG) Isolated from Flaxseed, an Alternative to ACE Inhibitors in the Treatment of Hypertension

Evaluation of the Inhibitory Activities of COVID-19 of Melaleuca cajuputi Oil Using Docking Simulation

Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2